Cardiac Rhythm Management
banner HRS 2019 SPAF

 

tmb invite SPAF2018

Date and Time:
Tuesday, May 7, 2019 • 7:00AM-6:00PM

Location:
San Francisco Marriott Marquis • Golden Gate A/B,
San Francisco, CA

 

 

 

Agenda

Agenda    
7:00AM–7:50AM   Registration and Breakfast
7:50AM–8:00AM   Opening Remarks
Vivek Reddy
    Session I
AF-Related Stroke and Anticoagulation – 1
Moderators: Jeremy Ruskin and Jonathan Hsu
8:00AM–8:10AM   Stroke Risk in the AF patient: It is more than just the CHADS-Vasc scor
Nassir Marrouche
8:10AM–8:20AM   Real-World Registry NOAC Outcomes: Relative Effectiveness & Compliance
John Camm
8:20AM–8:30AM   ICH and Major Hemorrhage Risk Compared Between Aspirin, Warfarin and NOACs
Edip Gurol
8:30AM–8:40AM   Underutilization of OAC in Patients with AF: Is there a role for more LAAC?
Jonathan Hsu
8:40AM–9:00AM   Panel Discussion
Moderators: Jeremy Ruskin and Jonathan Hsu
Panel: Nassir Marrouche, John Camm and Edip Gurol
    Session II
Watchman Implantation
Moderators: Vivek Reddy and Saibal Kar
9:00AM–9:10AM   Watchman Implantation: Tips and Tricks
Douglas Gibson
9:10AM–9:20AM   Pericardial Effusion: Incidence, Timing & Management
Boris Schmidt
9:20AM–9:30AM   ICE Guidance of LAAC under Conscious Sedation
Miguel Valderrábano
9:30AM–10:15AM   Watchman Implantation - Case Presentation
Operator: Srinivas Dukkipati
Moderators: Vivek Reddy and Saibal Kar
Panel: Douglas Gibson, Boris Schmidt, Miguel Valderrábano, and Anish Amin
10:15AM–10:35AM   Coffee Break
    Session III
LAA Closure Device Outcomes
Moderators: Moussa Mansour and Jonathan Piccini
10:35AM–10:45AM   Watchman Clinical Science Update
Saibal Kar
10:45AM–10:55AM   Amulet Clinical Science Update
Dhanunjaya Lakkireddy
10:55AM–11:05AM   AtriClip Outcomes
Felix Yang
11:05AM–11:15AM   Wavecrest Device: Clinical Experience in the US IDE Study
Jose Osorio
11:15AM–11:25AM   Lambre Outcomes
TBA
11:25AM–11:35AM   What is the Best Post-LAAC Antithrombotic Regimen?
Luigi Di Biase
11:35AM–12:05PM   Panel Discussion
Moderators: Moussa Mansour and Jonathan Piccini
Panel: Saibal Kar, Dhanunjaya Lakkireddy, Felix Yang, Jose Osorio and Luigi Di Biase
12:05PM–12:30PM   Working Lunch - Box Lunches
    Session IV
Watchman Coiling Procedure
Moderators: Shephal Doshi and Dhanunjaya Lakkireddy
12:30PM–12:40PM   Peri-Device Leaks: When are they important?
Moussa Mansour
12:40PM–12:50PM   Managing Incomplete LAA Closure (Surgical or LARIAT)
Christopher Ellis
12:50PM–1:00PM   Catheter Ablation to Close Peri-Device Leaks: Technique & Early Observations
Andrea Natale
1:00PM–1:30PM   Closing a Peri-Device Leak with Coils - Live Case Presentation
Operator: Rodney Horton
Moderators: Shephal Doshi and Dhanunjaya Lakkireddy
Panel: Moussa Mansour, Christopher Ellis, and Andrea Natale
    Session V
Upcoming LAA Closure Devices
Moderators: Boris Schmidt and TBA
1:30PM–1:40PM   What Is an Ideal LAAC Device?
Vijay Swarup
1:40PM–1:50PM   Watchman FLX Device
Ashish Sadhu
1:50PM–2:00PM   Next-Gen Lariat Device
Randall Lee
2:00PM–2:10PM   A Novel Foam LAA Closure Device
Vivek Reddy
2:10PM–2:20PM   “Baby” TEE Guidance of LAAC under Conscious Sedation
Lucas Boersma
2:20PM–2:30PM   A Novel Permanent Carotid Coil Filter for Stroke Prevention
Petr Neuzil
2:30PM–3:00PM   Panel Discussion
Moderators: Boris Schmidt and TBA
Panel: Vijay Swarup, Ashish Sadhu, Randall Lee, Vivek Reddy, Lucas Boersma, and Petr Neuzil
3:00PM–3:15PM   Coffee Break
    Session VI
AF-Related Stroke & Anticoagulation – 2
Moderators: Jeremy Ruskin and Andrea Natale
3:15PM–3:25PM   Subclinical Atrial Fibrillation: Incidence and Management
Taya Glotzer
3:25PM–3:35PM   Wearables in AF: Where are we, and where are we going?
Mintu Turakhia
3:35PM–3:45PM   ESUS: What is it? How to Prevent it? (OACs vs Anitplatelets)
Jeff Healey
3:45PM–3:55PM   Preserving Long-Term Neurologic Function – OAC vs LAAO
Jonathan Piccini
3:55PM–4:05PM   Stroke Risk after LAA Closure: Is LAAC Mandatory
K.R. Julian Chun
4:05PM–4:30PM   Panel Discussion
Moderators: Jeremy Ruskin and Andrea Natale
Panel: Taya Glotzer, Mintu Turakhia, Jeff Healey, Jonathan Piccini, and K.R. Julian Chun
    Session VII
Advancing the Clinical Science of LAA Closure
Moderators: John Camm and Jonathan Piccini
4:30PM–4:40PM   LAAC vs NOAC Trials: What is on the Horizon?
Pavel Osmancik
4:40PM–4:50PM   The OPTION Trial: Rationale and Design
Oussama Wazni
4:50PM–5:00PM   LAA Closure: Regulatory Perspectives on Advancing the Field
Andrew Farb
5:00PM–5:10PM   Simultaneous AF ablation & LAAC
Karen Philips
5:10PM–5:20PM   Same-Day Discharge After LAA Closure?
Shephal Doshi
5:20PM–5:30PM   Building an LAAC Referral Program
Devi Nair
5:30PM–5:35PM   Panel Discussion
Moderators: John Camm and Jonathan Piccini
Panel: Pavel Osmancik, Oussama Wazni, Andrew Farb, Karen Philips, Shephal Doshi, and Devi Nair
5:35PM–6:00PM   Closing Remarks and Adjourn

 

Cardiac Rhythm Management

Faculty

Program Director

   
Vivek Reddy, MD
The Mount Sinai Hospital
New York, NY
   


Invited Faculty

   

Anish Amin, MD
Ohio Health Physician Group
Columbus, OH

Lucas Boersma, MD, PhD
St. Antonius Hospital
Nieuwegein, The Netherlands

John Camm, MD
St. George’s University of London
London, England

K.R. Julian Chun, MD
Cardioangiologisches Centrum Bethanien – Markus Krankenhaus
Frankfurt, Germany

Luigi Di Biase, MD, PhD
Albert Einstein College of Medicine
Bronx, NY

Shephal Doshi, MD
Pacific Heart Institute
Santa Monica, CA

Srinivas Dukkipati, MD
The Mount Sinai Hospital
New York, NY

Christopher Ellis, MD
Vanderbilt Heart and Vascular Institute
Nashville, TN

Andrew Farb, MD
U.S. Food and Drug Administration
Silver Springs, MD

Douglas Gibson, MD
Scripps Green Hospital
La Jolla, CA

Taya Glotzer, MD
Hackensack University Medical Center
Hackensack, NJ

Edip Gurol, MD
Massachusetts General Hospital
Boston, MA

Jeff Healey, MD
McMaster University
Hamilton Ontario, Canada

Rodney Horton, MD
Texas Cardiac Arrhythmia Institute
Austin, TX

Jonathan Hsu, MD
University of California, San Diego
La Jolla, CA

Saibal Kar, MD
Cedars Sinai Medical Center
Los Angeles, CA

Dhanunjaya Lakkireddy, MD
The Kansas City Heart Rhythm Institute & Research Foundation,
Overland Park Regional Medical Center
Overland Park, KS

 

 

Randall Lee, MD, PhD
University of California San Francisco
San Francisco, CA

Moussa Mansour, MD
Massachusetts General Hospital
Boston, MA

Nassir Marrouche, MD
University of Utah Hospitals and Clinics
Salt Lake City, UT

Devi Nair, MD
St. Bernard’s Healthcare
Jonesboro, AR

Andrea Natale, MD
Texas Cardiac Arrhythmia Institute
Austin, TX

Petr Neuzil, MD, PhD
Homnolka Hospital
Prague, Czech Republic

Pavel Osmancik, MD, PhD
Charles University
Prague, Czech Republic

Jose Osorio, MD
Grandview Medical Center
Birmingham, AL

Karen Phillips, MBBS (Hons)
GenesisCare
Brisbane, Australia

Jonathan Piccini, MD
Duke University Medical Center
Durham, NC

Jeremy Ruskin, MD
Massachusetts General Hospital
Boston, MA

Ashish Sadhu, MD
Heart and Vascular Center of Arizona
Phoenix, AZ

Boris Schmidt, MD
Cardioangiologisches Centrum Bethanien
Frankfurt, Germany

Vijay Swarup MD, FACC, FHRS
Arizona Heart Rhythm Institute
Phoenix, AZ

Mintu Turakhia, MD
Stanford University and Palo Alto VA
Health Care System
Palo Alto, CA

Miguel Valderrábano, MD
Houston Methodist
Houston, TX

Felix Yang, MD
Maimonides Medical Center
Brooklyn, NY

Oussama Wazni, MD
Cleveland Clinic
Cleveland, OH

 

CME Activity Description

Activity Description
The symposium, led by the Program Director, Dr. Vivek Reddy from Mount Sinai Hospital, and world-renowned faculty experts, will once again explore the most recent advancements and developments in LAAC and oral anticoagulation therapy for managing AF related stroke. Featuring LAAC cases from leading institutions, insightful rapid-fire presentations, expert panel discussions, and engaging Q&A sessions, SPAF is a can’t miss meeting for physicians and associated healthcare professionals with an interest in evidence-based diagnostic and treatment strategies for stroke prophylaxis in AF patients.

Target Audience
This activity has been developed to meet the educational needs of electrophysiologists, interventional cardiologists, cardiologists, surgeons, and other physicians and associated healthcare professionals with an interest in the management of stroke in AF patients.

Learning Objectives
Upon completion of this educational activity, participants will be able to:

  • Identify how to use and reverse NOACs.
  • Discuss the role of the Left Atrial Appendage (LAA) in AF-related strokes.
  • Evaluate novel oral anticoagulation and advancements in Left Atrial Appendage Closure (LAAC) for stroke prophylaxis in AF.
  • Review strategies for balancing stroke vs bleeding in clinical practice.
  • Examine randomized clinical trial and registry data.
  • Review appropriate NOACC and LAAC patient selection criteria.
  • Assess the cost-effectiveness, efficacy and safety of LAAC therapy.
  • Evaluate optimal LAAC clinical decision making strategies and procedural approaches.
  • Examine catheter ablation with LAAC, including patient selection, clinical workflow and outcomes.
  • Assess clinical outcomes and practical aspects of LACC.

Accreditation Statement
Jointly Accredited Provider TMThis activity has been planned and implemented by Ciné-Med and MediaSphere Medical. Ciné-Med is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physicians: Ciné-Med designates this enduring activity for a maximum of 9 AMA PRA Category 1Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: This activity provides 9 contact hours for nurses.

Cardiac Rhythm Management

Disclosure Policy
MediaSphere Medical and Ciné-Med adheres to accreditation requirements regarding industry support of continuing medical education. Disclosure of the planning committee and faculty’s commercial relationships will be made known at the activity on course hand-outs and during faculty presentations. Speakers are required to openly disclose any limitations of data and/or any discussion of any off-label, experimental, or investigational uses of drugs or devices in their presentations.

All MediaSphere Medical and Ciné-Med employees in control of content have indicated that they have no relevant financial relationships to disclose.

It is the policy of MediaSphere Medical and Ciné-Med to ensure balance, independent objectivity, and scientific rigor in all its supported educational programs. All faculty members participating in educational activities are required to disclose to the program audience any real of apparent conflicts of interest held within the past 12 months.

MediaSphere Medical and Ciné-Med implement a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners. Faculty disclosures will be made available on the course syllabus book and faculty introductory slides.

Non-Endorsement Statement
MediaSphere Medical and Ciné-Med verifies that sound education principles have been demonstrated in the development of this educational offering as evidenced by the review of its objectives, teaching plan, faculty, and activity evaluation process. MediaSphere Medical and Ciné-Med does not endorse or support the actual opinions or material content as presented by the speaker(s) and/or sponsoring organization.

 

SPAF 2018

On-Demand Video Presentations from 2018 SPAF

Complimentary Access
We are pleased to provide complimentary and unlimited access to the on-demand video library from the 2018 Symposium on Stroke Prevention in Atrial Fibrillation Advancements in Oral Anticoagulation Therapy and LAA Closure. The presentation format consists of synched audio and video, along with the presenters slides.

Access 2018 Cases and presentations

 Click Here >>

 

tmb spaf17 vivek tmb spaf17 livecase tmb spaf17 panel

Cardiac Rhythm Management

 

 

“This program is not part of the Heart Rhythm 2019 Official Scientific Sessions as planned by the
Heart Rhythm Society Scientific Sessions Program Committee. The event is neither sponsored nor endorsed by the Heart Rhythm Society”